Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.

Cardiovascular diabetology - 26 Aug 2016

Ahmed Fahad W, Rider Rachel, Glanville Michael, Narayanan Kilimangalam, Razvi Salman, Weaver Jolanta U

Abstract excerpt

BACKGROUND: Type 1 diabetes is associated with increased cardiovascular disease (CVD). Decreased endothelial progenitor cells (EPCs) number plays a pivotal role in reduced endothelial repair and development of CVD. We aimed to determine if cardioprotective effect of metformin is mediated by increasing circulating endothelial progenitor cells (cEPCs), pro-angiogenic cells (PACs) and decreasing circulating...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Count
Share to Colony-Forming Units Assay

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Endothelial Cells

Share to Endothelial Progenitor Cells

Share to England

Share to Fibronectins

Share to Hypoglycemic Agents

Share to Metformin

Source

Open in PubMed Open full text

Identifiers

PMID: 27561827
DOI: 10.1186/s12933-016-0413-6
PMCID: PMC5000450

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Metformin improves circulating endothelial cells and endothelial progenitor cells in type 1 diabetes: MERIT study.PMID 27561827Read ↗

Linagliptin, when compared to placebo, improves CD34+ve Endothelial Progenitor Cells in Type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin, a randomized controlled trial.Semantic proximity Read ↗

Role of Canagliflozin on function of CD34+ endothelial progenitor cells (EPC) in patients with type 2 diabetesSemantic proximity Read ↗

Metformin improves the angiogenic potential of human CD34⁺ cells co-incident with downregulating CXCL10 and TIMP1 gene expression and increasing VEGFA under hyperglycemia and hypoxia within a therapeutic window for myocardial infarction.Semantic proximity Read ↗

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes.Semantic proximity Read ↗

High glucose-induced endothelial progenitor cell dysfunction.Semantic proximity Read ↗

Relationship between circulating endothelial progenitor cells and insulin resistance in non-diabetic patients with ischemic chronic heart failure.Semantic proximity Read ↗

Endothelial Progenitor Cell Dysfunction in Type 1 Diabetes: Another Consequence of Oxidative Stress?Semantic proximity Read ↗

Dapagliflozin restores diabetes-associated decline in vasculogenic capacity of endothelial progenitor cells via activating AMPK-mediated inhibition of inflammation and oxidative stressSemantic proximity Read ↗

Endothelial Progenitor Cell DysfunctionSemantic proximity Read ↗

Acute Effects of Linagliptin on Progenitor Cells, Monocyte Phenotypes, and Soluble Mediators in Type 2 Diabetes.Semantic proximity Read ↗

Human Endothelial Progenitor Cells From Type II Diabetics Exhibit Impaired Proliferation, Adhesion, and Incorporation Into Vascular StructuresSemantic proximity Read ↗

Diabetes, Endothelial Dysfunction, and Vascular Repair: What Should a Diabetologist Keep His Eye on?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.